Literature DB >> 31278057

T Cell Recruitment to the Intestinal Stem Cell Compartment Drives Immune-Mediated Intestinal Damage after Allogeneic Transplantation.

Ya-Yuan Fu1, Anastasiya Egorova1, Catherine Sobieski1, Jason Kuttiyara1, Marco Calafiore1, Shuichiro Takashima1, Hans Clevers2, Alan M Hanash3.   

Abstract

The key sites within the gastrointestinal (GI) tract where T cells mediate effector responses and the impact of these responses on intestinal stem cells (ISCs) remain unclear. Using experimental bone marrow transplantation to model immune-mediated GI damage and 3D imaging to analyze T cell localization, we found that the ISC compartment is the primary intestinal site targeted by T cells after transplantation. Recruitment to the crypt base region resulted in direct T cell engagement with the stem cell compartment and loss of crypt base columnar ISCs, which expressed both MHC classes I and II. Vasculature expressing the adhesion molecule MAdCAM-1 clustered near the crypt base, preferentially regulating crypt compartment invasion and ISC reduction without affecting T cell migration to villi. These findings indicate that allogeneic T cells rapidly access the stem cell niche after transplantation, and this targeted recruitment to the stem cell compartment results in ISC loss during immune-mediated GI damage.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BMT; GVHD; ISCs; LPAM; MAdCAM-1; Paneth cells; allogeneic bone marrow transplantation; beta7 integrin; graft versus host disease; imaging of immunity; intestinal stem cells; mucosal immunology; transplantation

Mesh:

Substances:

Year:  2019        PMID: 31278057      PMCID: PMC7239328          DOI: 10.1016/j.immuni.2019.06.003

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  70 in total

1.  In situ demonstration of intraepithelial lymphocyte adhesion to villus microvessels of the small intestine.

Authors:  S Koseki; S Miura; H Fujimori; R Hokari; S Komoto; Y Hara; T Ogino; H Nagata; M Goto; S Hachimura; S Kaminogawa; H Ishii
Journal:  Int Immunol       Date:  2001-09       Impact factor: 4.823

2.  Expression of nonclassical class I molecules by intestinal epithelial cells.

Authors:  Lilani Perera; Ling Shao; Anjlee Patel; Kelly Evans; Bertrand Meresse; Richard Blumberg; Daniel Geraghty; Veronika Groh; Thomas Spies; Bana Jabri; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2007-03       Impact factor: 5.325

3.  Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs.

Authors:  Andreas Beilhack; Stephan Schulz; Jeanette Baker; Georg F Beilhack; Ryosei Nishimura; Enosh M Baker; Gilad Landan; Edward I Herman; Eugene C Butcher; Christopher H Contag; Robert S Negrin
Journal:  Blood       Date:  2007-11-07       Impact factor: 22.113

4.  Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts.

Authors:  Toshiro Sato; Johan H van Es; Hugo J Snippert; Daniel E Stange; Robert G Vries; Maaike van den Born; Nick Barker; Noah F Shroyer; Marc van de Wetering; Hans Clevers
Journal:  Nature       Date:  2010-11-28       Impact factor: 49.962

5.  Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease.

Authors:  Ran Reshef; Selina M Luger; Elizabeth O Hexner; Alison W Loren; Noelle V Frey; Sunita D Nasta; Steven C Goldstein; Edward A Stadtmauer; Jacqueline Smith; Sarah Bailey; Rosemarie Mick; Daniel F Heitjan; Stephen G Emerson; James A Hoxie; Robert H Vonderheide; David L Porter
Journal:  N Engl J Med       Date:  2012-07-12       Impact factor: 91.245

6.  Intravital observation of adhesion of lamina propria lymphocytes to microvessels of small intestine in mice.

Authors:  Hitoshi Fujimori; Soichiro Miura; Seiichiro Koseki; Ryota Hokari; Shunsuke Komoto; Yuriko Hara; Satoshi Hachimura; Shuichi Kaminogawa; Hiromasa Ishii
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

7.  PTEN-deficient intestinal stem cells initiate intestinal polyposis.

Authors:  Xi C He; Tong Yin; Justin C Grindley; Qiang Tian; Toshiro Sato; W Andy Tao; Raminarao Dirisina; Kimberly S Porter-Westpfahl; Mark Hembree; Teri Johnson; Leanne M Wiedemann; Terrence A Barrett; Leroy Hood; Hong Wu; Linheng Li
Journal:  Nat Genet       Date:  2007-01-21       Impact factor: 38.330

8.  Dynamic T cell migration program provides resident memory within intestinal epithelium.

Authors:  David Masopust; Daniel Choo; Vaiva Vezys; E John Wherry; Jaikumar Duraiswamy; Rama Akondy; Jun Wang; Kerry A Casey; Daniel L Barber; Kim S Kawamura; Kathryn A Fraser; Richard J Webby; Volker Brinkmann; Eugene C Butcher; Kenneth A Newell; Rafi Ahmed
Journal:  J Exp Med       Date:  2010-02-15       Impact factor: 14.307

9.  Vedolizumab as induction and maintenance therapy for ulcerative colitis.

Authors:  Brian G Feagan; Paul Rutgeerts; Bruce E Sands; Stephen Hanauer; Jean-Frédéric Colombel; William J Sandborn; Gert Van Assche; Jeffrey Axler; Hyo-Jong Kim; Silvio Danese; Irving Fox; Catherine Milch; Serap Sankoh; Tim Wyant; Jing Xu; Asit Parikh
Journal:  N Engl J Med       Date:  2013-08-22       Impact factor: 91.245

10.  Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease.

Authors:  L Mayer; D Eisenhardt; P Salomon; W Bauer; R Plous; L Piccinini
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

View more
  29 in total

Review 1.  Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease.

Authors:  Tomomi Toubai; John Magenau
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 2.  The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease.

Authors:  Motoko Koyama; Geoffrey R Hill
Journal:  Blood       Date:  2019-12-12       Impact factor: 22.113

3.  T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage.

Authors:  S Takashima; M L Martin; S A Jansen; Y Fu; J Bos; D Chandra; M H O'Connor; A M Mertelsmann; P Vinci; J Kuttiyara; S M Devlin; S Middendorp; M Calafiore; A Egorova; M Kleppe; Y Lo; N F Shroyer; E H Cheng; R L Levine; C Liu; R Kolesnick; C A Lindemans; A M Hanash
Journal:  Sci Immunol       Date:  2019-12-06

4.  Integrin αEβ7+ T cells direct intestinal stem cell fate decisions via adhesion signaling.

Authors:  Shiyang Chen; Yajuan Zheng; Xiaojuan Ran; Hui Du; Hua Feng; Lei Yang; Yating Wen; Changdong Lin; Shihui Wang; Mengwen Huang; Zhanjun Yan; Dianqing Wu; Hongyan Wang; Gaoxiang Ge; An Zeng; Yi Arial Zeng; Jianfeng Chen
Journal:  Cell Res       Date:  2021-09-13       Impact factor: 25.617

Review 5.  New therapeutic targets and biomarkers for acute graft-versus-host disease (GVHD).

Authors:  Hannah Choe; James L M Ferrara
Journal:  Expert Opin Ther Targets       Date:  2021-11-01       Impact factor: 6.902

6.  GCNT1-Mediated O-Glycosylation of the Sialomucin CD43 Is a Sensitive Indicator of Notch Signaling in Activated T Cells.

Authors:  Eric Perkey; Dave Maurice De Sousa; Léolène Carrington; Jooho Chung; Alexander Dils; David Granadier; Ute Koch; Freddy Radtke; Burkhard Ludewig; Bruce R Blazar; Christian W Siebel; Todd V Brennan; Jeffrey Nolz; Nathalie Labrecque; Ivan Maillard
Journal:  J Immunol       Date:  2020-02-14       Impact factor: 5.422

Review 7.  The role of T cells in age-related diseases.

Authors:  Elisa Carrasco; Manuel M Gómez de Las Heras; Enrique Gabandé-Rodríguez; Gabriela Desdín-Micó; Juan Francisco Aranda; Maria Mittelbrunn
Journal:  Nat Rev Immunol       Date:  2021-06-07       Impact factor: 53.106

Review 8.  Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host disease.

Authors:  Gérard Socié; Leslie S Kean; Robert Zeiser; Bruce R Blazar
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 19.456

9.  Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis.

Authors:  Semir Beyaz; Charlie Chung; Haiwei Mou; Khristian E Bauer-Rowe; Michael E Xifaras; Ilgin Ergin; Lenka Dohnalova; Moshe Biton; Karthik Shekhar; Onur Eskiocak; Katherine Papciak; Kadir Ozler; Mohammad Almeqdadi; Brian Yueh; Miriam Fein; Damodaran Annamalai; Eider Valle-Encinas; Aysegul Erdemir; Karoline Dogum; Vyom Shah; Aybuke Alici-Garipcan; Hannah V Meyer; Deniz M Özata; Eran Elinav; Alper Kucukural; Pawan Kumar; Jeremy P McAleer; James G Fox; Christoph A Thaiss; Aviv Regev; Jatin Roper; Stuart H Orkin; Ömer H Yilmaz
Journal:  Cell Stem Cell       Date:  2021-09-15       Impact factor: 25.269

10.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.

Authors:  Daniel Wolff; Vedran Radojcic; Robert Lafyatis; Resat Cinar; Rachel K Rosenstein; Edward W Cowen; Guang-Shing Cheng; Ajay Sheshadri; Anne Bergeron; Kirsten M Williams; Jamie L Todd; Takanori Teshima; Geoffrey D E Cuvelier; Ernst Holler; Shannon R McCurdy; Robert R Jenq; Alan M Hanash; David Jacobsohn; Bianca D Santomasso; Sandeep Jain; Yoko Ogawa; Philipp Steven; Zhonghui Katie Luo; Tina Dietrich-Ntoukas; Daniel Saban; Ervina Bilic; Olaf Penack; Linda M Griffith; Meredith Cowden; Paul J Martin; Hildegard T Greinix; Stefanie Sarantopoulos; Gerard Socie; Bruce R Blazar; Joseph Pidala; Carrie L Kitko; Daniel R Couriel; Corey Cutler; Kirk R Schultz; Steven Z Pavletic; Stephanie J Lee; Sophie Paczesny
Journal:  Transplant Cell Ther       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.